The therapeutic window for acute ischemic stroke with intravenous recombinant tissue plasminogen activator (IV rt-PA) is brief and crucial. The American Heart Association/American Stroke Association Target: Stroke Best Practice Strategies (TSBPS) aim to improve intravenous thrombolysis door-to-needle (DTN) time. We assessed the efficacy of implementation of selected TSBPS to reduce DTN time in a large tertiary care hospital. A multidisciplinary DTN committee assessed causes of delayed DTN time and implemented focused TSBPS in our urban academic medical center. We analyzed door-to-CT time, DTN time, and CT to IV rt-PA time in consecutive patients treated with IV rt-PA over 27 months preimplementation and 13 months postimplementation. One hundred forty-eight patients were included in the preimplementation and 126 in the postimplementation group. We found no significant difference between the groups in demographics, comorbidities, anticoagulation status, prethrombolysis hypertension treatment, arrival by EMS, after-hours arrival, or in stroke etiology. After implementation, median DTN time improved from 59 (interquartile range [IQR]: 52-80) to 29 (IQR: 20-41) minutes (P < .001). Door-to-CT time decreased from 17 (14-21) to 16 (12-19) minutes (P ¼ .016), and CT-to-IV rt-PA time improved from 43 (IQR: 31-59) to 13 (IQR: 6-23) minutes (P < .001). Rates of symptomatic intracranial hemorrhage (2.7% vs 3.2%, P ¼ .82) and treatment of stroke mimics (9% vs 13%, P ¼ .31) were similar in both the groups. Individualized hospital gap analysis identifies targeted interventions that lead to rapid and sustained improvement in treatment times.
Introduction
Thrombolysis with intravenous recombinant tissue plasminogen activator (IV rt-PA) has been shown to decrease the longterm morbidity in patients with acute ischemic stroke (AIS). 1 This effect is time sensitive, with earlier thrombolysis leading to increased rate of functional independence and lower rates of complications. 2 National Registry data reported that less than 30% of patients with AIS eligible for treatment with IV rt-PA receive it within the first hour of presentation. 3 After the success of Target Stroke: Best Practice Strategies (TSBPS: phase I) which was a quality improvement initiative launched by American Heart Association/American Stroke Association focused on delivery of acute stroke care across hospitals in the United States, 4 a phase II initiative was launched in 2014 that delineated 11 strategies with the intent to further reduce the door-to-needle (DTN) times for IV thrombolysis 5 We implemented selected strategies from TSBPS (phase II) at Jackson Memorial Hospital, a 1550-bed acute care urban tertiary academic center with about 900 stroke admissions each year. We analyzed the effect of implementation of these strategies on acute stroke care metrics.
Methods
A multidisciplinary council consisting of members from the Departments of Neurology, Emergency Medicine, Pharmacy, and Radiology was tasked with identifying factors contributing to delays in DTN times. This council found that there were delays at various stages in identification of an acute stroke and subsequent notification of the neurology team. Moreover, the time from obtaining noncontrast head CT scan to delivery of IV rt-PA was substantial. Based on this gap analysis, 5 strategies from TSBPS were implemented: EMS prenotification, direct transfer from ambulance to CT scanner, storing and administering IV rt-PA in the CT scanner, team-based approach, and prompt data feedback to all involved parties. These interventions were implemented simultaneously beginning on March 22, 2015.
Consecutive patients presenting to the Jackson Memorial Hospital emergency department (ED) who were treated for AIS with IV rt-PA between January 1, 2013, and April 30, 2016, were included in this analysis. Data for patients in the postimplementation phase (March 22, 2015-April 30, 2016) were collected prospectively, while data for patients in the preimplementation phase were reviewed retrospectively (January 01, 2013-March 21, 2015). This study was approved by the local institutional review board which waived the need for written consent from patients. All consecutive patients treated with IV rt-PA, except 3 patients enrolled in an ongoing AIS treatment clinical trial, were included in the analysis.
We evaluated patient demographics, vascular risk factors, and acute stroke care characteristics. Stroke mechanism was classified according to TOAST classification or as stroke mimic.
Patients were analyzed by preimplementation and postimplementation time periods. The primary outcome was DTN time. Secondary outcomes included door-to-CT (DTCT) time and CT to IV rt-PA time, thrombolysis-related complications, and stroke mimic treatment rate.
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, version 24, IBM Corporation, Armonk, New York). Between groups, comparisons were made with t test and w 2 as appropriate. Statistical significance was determined by P value of <.05.
Results
A total of 274 patients were analyzed, 148 patients in the preimplementation group and 126 patients in the postimplementation group. Both the groups were similar for baseline demographics, vascular risk factors, median NIHSS, and stroke mechanisms. There was a significant increase in the rate of stroke team prearrival notification in the postimplementation group (60% vs 2%, P < .01; Table 1 ).
Median (interquartile range [IQR]) DTN time was reduced by 51%, from 59 (52-80) to 29 (20-41) minutes, (P < .001). Median DTCT decreased from 17 (14-21) to 16 (12-19) minutes (P ¼ .016). Median CT-to-IV r-tPA time decreased from 43 (31-59) to 13 (6-23) minutes (P < .001; Table 2 ). There was no significant difference in symptomatic systemic bleeding (1% vs 3%, P ¼ .31), Symptomatic Intracranial Hemorrhage. (sICH) (2.7% pre vs 3.1% post, P ¼ .82; Table 2 ), or stroke mimic treatment rate between the 2 groups (9% vs 12%, P ¼ .31; Table 1 ). The reduction in DTN time was sustained as illustrated in Figure 1 .
Discussion
Since most of the TSBPS (phase I) strategies were already functional at our institution, we believe implementation of the following recommendations from TSBPS phase II greatly helped decrease our DTN times.
EMS Prenotification
There is strong evidence to support the prearrival activation to improve treatment times. 6 The practice prior to TSBPS implementation included EMS prenotification of ED team while en-route, but the stroke team was activated with a single call when the patient was assessed by the ED physician per TSBPS (phase I) recommendations. After implementation, EMS prenotification activated the stroke team and support staff with a single call who then waited for the patient at the ambulance bay.
Transfer Directly to CT Scanner
Preimplementation, patients suspected of having a stroke for which a stroke alert was activated were first taken to an ED bed for vitals, initial laboratory tests, and IV placement. After implementation, stable patients were taken directly from ambulance bay to the CT scanner. The ED team would evaluate the patient for respiratory and hemodynamic stability upon arrival and transport to the CT scanner simultaneously while the stroke team performed a quick neurological assessment.
Storage and Administration of IV rt-PA in the CT Scanner
Prior to implementation, eligible patients were taken from the CT scanner to the ED, where IV rt-PA was administered. After implementation, IV rt-PA and infusion equipment were stored, and drug was administered to eligible patients while in the CT scanner. Our study showed a significant reduction in CT to IV rt-PA times from 43 to 13 minutes (median times).
Team-Based Approach and Prompt Data Feedback to Stakeholders
All these efforts were strongly complemented by a robust and immediate feedback system which allowed for continuous improvement in workflow. Each case would be scrutinized for DTN by the multidisciplinary council on a daily basis. Any delays in each of those cases would be thoroughly investigated, and the recommendations to avoid those delays for future cases would be sent to all the relevant stakeholders involved immediately, within the next day.
Target: Stroke Best Practice Strategies have been adopted nationwide with reported decreases in median DTN from 77 to 67 minutes using some of these strategies. 4 Similar strategies to reduce DTN times have been adopted at several institutions, and the minimum median DTN time reported in the United States is 39 minutes. 7 The national goals identified in TSBPS phase II were to achieve DTN times of <60 and 45 minutes in greater than 50% and 75% of patients with AIS receiving IV rt-PA, and the projected benefit from these strategies was anticipated to be a decrease in median DTN times by 14 minutes. 5 As shown in our report, the results these interventions helped our institution achieve are superior to these projected goals and serve as a benchmark that stroke centers should adopt in establishing their goals in terms of treatment times. Moreover, since initial treatment is provided by different levels of trainees under supervision at our center, this rapid and consistent reduction in treatment times establishes the reliability of these best practices and reproducibility of these results despite variability in providers.
In our study, the rate of thrombolysis in patients in the postimplementation group (9.7 patients/month) was significantly higher than preimplementation group (5.5 patients/ month). Since the total number of stroke admissions remained similar across the period of study, we believe the fact that with reduced time to treatment, more patients became eligible for intravenous thrombolysis may have contributed to increase in utilization of IV rt-PA, although we acknowledge that simultaneously there has been an increase in awareness of stroke care among the public and health-care providers. Moreover, sICH and treatment of stroke mimics was similar in both groups. Thus, an impetus toward faster treatment times did not result in a more cursory evaluation of the patient. Although ours is a single-center study, it is representative of a large and diverse patient population. These results emphasize that process improvement is rewarding and important for management of patients with stroke. This study focuses on acute stroke treatment metrics, specifically DTN times, and we do not have sufficient data to assess 90-day outcomes. However, there is strong evidence to support that earlier treatment times result in improved patient outcomes.
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Conclusion
Implementation of targeted process improvement interventions requires real-time, coordinated team effort and leads to dramatic and sustained reductions in time to thrombolysis treatment.
